UBS lowered the firm’s price target on Dentsply Sirona (XRAY) to $25 from $27 and keeps a Buy rating on the shares.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona’s Q1 2025 Financial Performance Overview
- DENTSPLY SIRONA: Strong Earnings Overshadowed by Leadership Changes and Market Uncertainties
- DENTSPLY SIRONA: Hold Rating Amid Stabilizing Growth and Macro Challenges
- Dentsply Sirona’s Earnings Call: Growth Amid Challenges
- Cautious Optimism for DENTSPLY SIRONA Amid Recovery and Challenges: Hold Rating Maintained with Price Target at $17